n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with Atherogenesis in 3 studies
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide: structure given in first source
NS-398 : A C-nitro compound that is N-methylsulfonyl-4-nitroaniline bearing an additional cyclohexyloxy substituent at position 2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The finding that LSS-dependent reduction of TNF-alpha generation and HO-1 induction were abrogated by the selective inhibitor of COX-2 NS-398, the nonselective COX inhibitor aspirin, or the specific prostacyclin receptor (IP) antagonist RO3244794 illuminates the central role played by LSS-induced COX-2-dependent prostacyclin in restraining endothelial inflammation." | 3.75 | Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells. ( Dercho, RA; Di Francesco, A; Di Francesco, L; Dovizio, M; Evangelista, V; Pandolfi, A; Patrignani, P; Piccoli, A; Salvatore, T; Seta, F; Totani, L, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friesen, RW | 1 |
| Mancini, JA | 1 |
| Di Francesco, L | 1 |
| Totani, L | 1 |
| Dovizio, M | 1 |
| Piccoli, A | 1 |
| Di Francesco, A | 1 |
| Salvatore, T | 1 |
| Pandolfi, A | 1 |
| Evangelista, V | 1 |
| Dercho, RA | 1 |
| Seta, F | 1 |
| Patrignani, P | 1 |
| Taketa, K | 1 |
| Matsumura, T | 1 |
| Yano, M | 1 |
| Ishii, N | 1 |
| Senokuchi, T | 1 |
| Motoshima, H | 1 |
| Murata, Y | 1 |
| Kim-Mitsuyama, S | 1 |
| Kawada, T | 1 |
| Itabe, H | 1 |
| Takeya, M | 1 |
| Nishikawa, T | 1 |
| Tsuruzoe, K | 1 |
| Araki, E | 1 |
3 other studies available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and Atherogenesis
| Article | Year |
|---|---|
Microsomal prostaglandin E2 synthase-1 (mPGES-1): a novel anti-inflammatory therapeutic target.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Atherosclerosis; Fever; Humans; Intramolecular Oxi | 2008 |
Induction of prostacyclin by steady laminar shear stress suppresses tumor necrosis factor-alpha biosynthesis via heme oxygenase-1 in human endothelial cells.
Topics: 6-Ketoprostaglandin F1 alpha; Aspirin; Atherosclerosis; Benzofurans; Cells, Cultured; Cyclooxygenase | 2009 |
Oxidized low density lipoprotein activates peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARgamma through MAPK-dependent COX-2 expression in macrophages.
Topics: Animals; Apolipoproteins E; Atherosclerosis; Cell Line; Cyclooxygenase 2; Cyclooxygenase Inhibitors; | 2008 |